Lv5
1450 积分 2023-11-24 加入
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
3天前
已完结
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
3天前
已完结
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors
10天前
已完结
Quadruple pegRNA enables programmable and efficient large genomic insertion
17天前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
19天前
已完结
Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ
1个月前
已完结
Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population
1个月前
已完结
Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response
1个月前
已完结
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity
1个月前
已完结
903 Phase I trial of tandem intravenous and intraperitoneal delivery of IL-12 armored CAR T cells targeting MUC16 in patients with recurrent high-grade serous ovarian cancer
2个月前
已关闭
皖公网安备34019202002308
